Literature DB >> 22031707

Disseminated Mycobacterium chelonae infection in a patient receiving an epidermal growth factor receptor inhibitor for advanced head and neck cancer.

Charles M Bark1, Rana S Traboulsi, Kord Honda, Autumn M Starnes, Michael R Jacobs, Benigno Rodriguez.   

Abstract

We report a case of disseminated cutaneous Mycobacterium chelonae infection in a patient with head and neck cancer on salvage chemotherapy, including the epidermal growth factor receptor inhibitor cetuximab. Mycobacterium chelonae should be considered in the differential diagnosis of cutaneous infections in cancer patients receiving epidermal growth factor receptor inhibitors.

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 22031707      PMCID： PMC3256709          DOI： 10.1128/JCM.05399-11

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  12 in total

1.  Mycobacterium chelonae infection associated with adalimumab therapy.

Authors:  F Díaz; J C Urkijo; F Mendoza; J M de la Viuda; M Blanco; A Unzurrunzaga; R Ayarza
Journal:  Scand J Rheumatol       Date:  2008 Mar-Apr       Impact factor: 3.641

2.  Epidermal growth factor-binding protein in Mycobacterium avium and Mycobacterium tuberculosis: a possible role in the mechanism of infection.

Authors:  L E Bermudez; M Petrofsky; K Shelton
Journal:  Infect Immun       Date:  1996-08       Impact factor: 3.441

3.  Dermatologic infections in cancer patients treated with epidermal growth factor receptor inhibitor therapy.

Authors:  R E Eilers; M Gandhi; J D Patel; M F Mulcahy; M Agulnik; T Hensing; Mario E Lacouture
Journal:  J Natl Cancer Inst       Date:  2009-12-09       Impact factor: 13.506

4.  Skin, soft tissue, and bone infections due to Mycobacterium chelonae chelonae: importance of prior corticosteroid therapy, frequency of disseminated infections, and resistance to oral antimicrobials other than clarithromycin.

Authors:  R J Wallace; B A Brown; G O Onyi
Journal:  J Infect Dis       Date:  1992-08       Impact factor: 5.226

5.  PCR amplification and restriction endonuclease analysis of a 65-kilodalton heat shock protein gene sequence for taxonomic separation of rapidly growing mycobacteria.

Authors:  V A Steingrube; J L Gibson; B A Brown; Y Zhang; R W Wilson; M Rajagopalan; R J Wallace
Journal:  J Clin Microbiol       Date:  1995-01       Impact factor: 5.948

Review 6.  Skin toxicities associated with epidermal growth factor receptor inhibitors.

Authors:  Tianhong Li; Roman Perez-Soler
Journal:  Target Oncol       Date:  2009-05-19       Impact factor: 4.493

7.  Cetuximab monotherapy and cetuximab plus irinotecan in irinotecan-refractory metastatic colorectal cancer.

Authors:  David Cunningham; Yves Humblet; Salvatore Siena; David Khayat; Harry Bleiberg; Armando Santoro; Danny Bets; Matthias Mueser; Andreas Harstrick; Chris Verslype; Ian Chau; Eric Van Cutsem
Journal:  N Engl J Med       Date:  2004-07-22       Impact factor: 91.245

8.  Cetuximab for the treatment of colorectal cancer.

Authors:  Derek J Jonker; Chris J O'Callaghan; Christos S Karapetis; John R Zalcberg; Dongsheng Tu; Heather-Jane Au; Scott R Berry; Marianne Krahn; Timothy Price; R John Simes; Niall C Tebbutt; Guy van Hazel; Rafal Wierzbicki; Christiane Langer; Malcolm J Moore
Journal:  N Engl J Med       Date:  2007-11-15       Impact factor: 91.245

Review 9.  Clinical and taxonomic status of pathogenic nonpigmented or late-pigmenting rapidly growing mycobacteria.

Authors:  Barbara A Brown-Elliott; Richard J Wallace
Journal:  Clin Microbiol Rev       Date:  2002-10       Impact factor: 26.132

10.  Analysis of the anti-tumor effect of cetuximab using protein kinetics and mouse xenograft models.

Authors:  Teppei Matsuo; Satoshi S Nishizuka; Kazushige Ishida; Takeshi Iwaya; Miyuki Ikeda; Go Wakabayashi
Journal:  BMC Res Notes       Date:  2011-05-10
View more
  4 in total

1.  A review of cutaneous toxicities from targeted therapies in the treatment of colorectal cancers.

Authors:  Christopher Urban; Milan J Anadkat
Journal:  J Gastrointest Oncol       Date:  2013-09

2.  A Case of Disseminated Sepsis Caused by an Unusual Microorganism in a Patient With Diabetes.

Authors:  Carolina Gherman-Ciolac; Amish Patel; Salim Budha; Joanna Macve; Harit Buch
Journal:  Clin Diabetes       Date:  2017-04

3.  Mycobacterium chelonae cutaneous infection: An opportunistic disease in an immunosuppressed patient with myasthenia gravis.

Authors:  Joana Granado; Ana Cláudia Miranda; Marco Fernandes; Luís Santos; Kamal Mansinho
Journal:  IDCases       Date:  2020-05-13

4.  Successful Treatment of a Renal Abscess Caused by Mycobacterium chelonae: A Case Report.

Authors:  Elizabeth Verghese; Ahmad Jabri; Richard R Watkins
Journal:  Open Forum Infect Dis       Date:  2018-08-16       Impact factor: 3.835
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.